Skip to Content
Merck
  • Long-term high-fat diet-induced obesity decreases the cardiac leptin receptor without apparent lipotoxicity.

Long-term high-fat diet-induced obesity decreases the cardiac leptin receptor without apparent lipotoxicity.

Life sciences (2011-04-05)
André F Nascimento, Renata A M Luvizotto, André S Leopoldo, Ana P Lima-Leopoldo, Fábio R Seiva, Luís A Justulin, Maeli Dal Pai Silva, Katashi Okoshi, Xiang-Dong Wang, Antonio C Cicogna
ABSTRACT

Leptin resistance has been associated with cardiac lipotoxicity; however, whether leptin resistance is a risk factor associated with cardiac lipotoxicity at different time points in diet-induced obesity is unclear. The objective of this study was to evaluate this relationship. Male Wistar rats were fed a normal chow diet (12% from fat) or a high-fat diet (49% from fat) for 15 and 45 weeks, respectively. The adiposity index, body weight and co-morbidities were evaluated. Heart lipotoxicity was assessed by analyzing cardiac function and morphological changes as well as cardiac triglyceride, ceramide and lipid hydroperoxide accumulations. Cardiac apoptosis was examined using the TUNEL method. Leptin function was determined by examining plasma leptin levels, cardiac leptin receptors (OB-R) and related phosphorylations of AMP-activated kinase protein (AMPK) and Acetyl CoA carboxylase (ACC). The diet-induced obesity was characterized by an elevated adiposity index, body weight and leptin levels at both 15 and 45 weeks. There was no difference between groups in the cardiac triglyceride or lipid hydroperoxide levels. Interestingly, ceramide levels decreased in obese animals in both experimental periods. The cardiac morphological and functional parameters were not altered. Although down-regulation of OB-R has occurred in chronic obesity, it did not adversely affect AMPK or ACC phosphorylation. The development of obesity via long-term feeding of a high-fat diet to rats does not result in cardiac lipotoxicity but promotes the down-regulation of OB-R. However, this does not result in altered levels of AMPK or ACC phosphorylations in this animal model.

MATERIALS
Product Number
Brand
Product Description

Avanti
C16 Ceramide (d18:1/16:0), Avanti Research - A Croda Brand
Avanti
C17 Ceramide (d18:1/17:0), Avanti Research - A Croda Brand